Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  CSPC Pharmaceutical Group Limited    1093   HK1093012172

CSPC PHARMACEUTICAL GROUP LIMITED

(1093)
  Report
End-of-day quote. End-of-day quote Hong Kong Stock Exchange - 06/04
16.02 HKD   -0.25%
05/27CSPC Pharmaceutical's 1Q Net Profit Rose 22%
DJ
05/22CSPC PHARMACEUTICAL GROUP LIMITED : quaterly earnings release
03/30CSPC PHARMACEUTICAL : 2019 Net Profit Rose 21%
DJ
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
05/29/2020 06/01/2020 06/02/2020 06/03/2020 06/04/2020 Date
15.18 15.66 16.38 16.06 16.02 Last
66001740 54561640 60316990 46622380 30369250 Volume
-0.13% +3.16% +4.60% -1.95% -0.25% Change
Financials
Sales 2020 27 854 M 3 594 M 3 594 M
Net income 2020 4 681 M 604 M 604 M
Net cash position 2020 6 303 M 813 M 813 M
P/E ratio 2020 21,1x
Yield 2020 1,48%
Sales 2021 33 810 M 4 363 M 4 363 M
Net income 2021 5 773 M 745 M 745 M
Net cash position 2021 10 218 M 1 319 M 1 319 M
P/E ratio 2021 17,2x
Yield 2021 1,71%
Capitalization 99 612 M 12 853 M 12 854 M
EV / Sales 2020 3,35x
EV / Sales 2021 2,64x
Nbr of Employees 17 300
Free-Float 70,3%
More Financials
Company
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows: - drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%); - vitamin C (10.1%); - antibiotics (6.2%); - other (5%): including anhydrous and raw caffeine. Net sales are distributed geographically as follows: China... 
Sector
Pharmaceuticals
Calendar
06/14 | 10:00pmShareholder meeting
More about the company
Surperformance© ratings of CSPC Pharmaceutical Group
Trading Rating : Investor Rating :
More Ratings
Latest news on CSPC PHARMACEUTICAL GROUP
05/27CSPC Pharmaceutical's 1Q Net Profit Rose 22%
DJ
05/22CSPC PHARMACEUTICAL GROUP LIMITED : quaterly earnings release
03/30CSPC PHARMACEUTICAL : 2019 Net Profit Rose 21%
DJ
03/09CSPC PHARMACEUTICAL : Voluntary announcement - drug registration approval of the..
PU
02/25CSPC PHARMACEUTICAL : Voluntary announcement - drug registration approval of the..
PU
02/24CSPC PHARMACEUTICAL : Inside information - preliminary results of cspc innovatio..
PU
02/24CSPC PHARMACEUTICAL : Voluntary announcement - investigational new drug almb-016..
PU
02/24CSPC PHARMACEUTICAL GROUP LIMITED : Annual results
CO
01/02CSPC PHARMACEUTICAL : Voluntary announcement - drug registration approval of the..
PU
01/02CSPC PHARMACEUTICAL : Voluntary announcement - drug registration approval of the..
PU
2019CSPC PHARMACEUTICAL : Voluntary announcement - the group's "pregabalin capsules"..
PU
2019CSPC PHARMACEUTICAL : Voluntary announcement - termination of product co-develop..
PU
2019CSPC PHARMACEUTICAL : Voluntary announcement - new drug approval of the group's ..
PU
2019CSPC PHARMACEUTICAL : Voluntary announcement - passing of consistency evaluation..
PU
2019CSPC PHARMACEUTICAL : Revision of annual caps for existing continuing connected ..
PU
More news
News in other languages on CSPC PHARMACEUTICAL GROUP
05/27CSPC PHARMACEUTICAL : limite les dégâts au 1er trimestre, malgré le confinement ..
05/27CSPC Pharmaceutical's 1Q Net Profit Rose 22%
05/22CSPC PHARMACEUTICAL GROUP LIMITED : quaterly earnings release
05/22CSPC PHARMACEUTICAL GROUP LIMITED : Veröffentlichung des Quartalsergebnisses
05/22CSPC PHARMACEUTICAL GROUP LIMITED : publication des résultats trimestriels
More news
Chart CSPC PHARMACEUTICAL GROUP LIMITED
Duration : Period :
CSPC Pharmaceutical Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSPC PHARMACEUTICAL GROUP
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 31
Average target price 21,10 HKD
Last Close Price 16,02 HKD
Spread / Highest target 69,8%
Spread / Average Target 31,7%
Spread / Lowest Target 6,12%
EPS Revisions
Managers
NameTitle
Dong Chen Cai Chairman & Co-Chief Executive Officer
Cuilong Zhang Vice Chairman & Co-Chief Executive Officer
Wei Dong Pan Executive Director
Ka Sze Lee Secretary & Non-Executive Director
Huai Yu Wang Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CSPC PHARMACEUTICAL GROUP LIMITED-13.78%12 885
JOHNSON & JOHNSON1.91%391 632
ROCHE HOLDING AG7.99%300 089
MERCK & CO., INC.-9.77%207 128
PFIZER, INC.-7.71%200 863
NOVARTIS AG-10.25%188 902